| 1. |
- Konopelko, D., et al.
(författare)
-
Precambrian gold mineralization at Djamgyr in the Kyrgyz Tien Shan : Tectonic and metallogenic implications
- 2017
-
Ingår i: Ore Geology Reviews. - : Elsevier BV. - 0169-1368. ; 86, s. 537-547
-
Tidskriftsartikel (refereegranskat)abstract
- The Djamgyr gold deposit is located within the Neoproterozoic basement of the Middle Tien Shan terrane immediately west of the Talas-Fergana fault. The deposit comprises a system of auriferous quartz veins cross-cutting the Beshtor plagiogranite. The veins are surrounded by hydrothermal alteration aureoles and are oriented parallel to the Talas-Fergana fault. The Beshtor granite sampled in the vicinity of the deposit yielded a Neoproterozoic (Tonian) U-Pb zircon age of 815 ± 6 Ma, which is the first single grain zircon age of the Middle Tien Shan basement west of the Talas-Fergana fault. Ar-Ar dating of two muscovite fractions from the alteration aureoles of the auriferous quartz veins yielded ages of 804 ± 3 and 805 ± 3 Ma suggesting that the mineralization in the Djamgyr deposit occurred during the Neoproterozoic ca. 10 m.y. after emplacement of the Beshtor granite. The structural pattern of the auriferous quartz veins and the new geochronological data, combined with the results of previous structural studies, may tentatively constrain the age of pre-existing major fault possibly marking an inherited terrane boundary in the northern part of the present-day Talas-Fergana strike-slip fault. The discovery of Precambrian gold mineralization in the Middle Tien Shan suggests re-evaluation of the metallogenic potential of its Precambrian basement that occupies significant areas west and east of the Talas-Fergana fault.
|
|
| 2. |
- Ravnskov, U., et al.
(författare)
-
Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
- 2016
-
Ingår i: Bmj Open. - : BMJ. - 2044-6055. ; 6:6
-
Tidskriftsartikel (refereegranskat)abstract
- Objective It is well known that total cholesterol becomes less of a risk factor or not at all for all-cause and cardiovascular (CV) mortality with increasing age, but as little is known as to whether low-density lipoprotein cholesterol (LDL-C), one component of total cholesterol, is associated with mortality in the elderly, we decided to investigate this issue. Setting, participants and outcome measures We sought PubMed for cohort studies, where LDL-C had been investigated as a risk factor for all-cause and/or CV mortality in individuals 60years from the general population. Results We identified 19 cohort studies including 30 cohorts with a total of 68094 elderly people, where all-cause mortality was recorded in 28 cohorts and CV mortality in 9 cohorts. Inverse association between all-cause mortality and LDL-C was seen in 16 cohorts (in 14 with statistical significance) representing 92% of the number of participants, where this association was recorded. In the rest, no association was found. In two cohorts, CV mortality was highest in the lowest LDL-C quartile and with statistical significance; in seven cohorts, no association was found. Conclusions High LDL-C is inversely associated with mortality in most people over 60years. This finding is inconsistent with the cholesterol hypothesis (ie, that cholesterol, particularly LDL-C, is inherently atherogenic). Since elderly people with high LDL-C live as long or longer than those with low LDL-C, our analysis provides reason to question the validity of the cholesterol hypothesis. Moreover, our study provides the rationale for a re-evaluation of guidelines recommending pharmacological reduction of LDL-C in the elderly as a component of cardiovascular disease prevention strategies.
|
|
| 3. |
- Ravnskov, U., et al.
(författare)
-
LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature
- 2018
-
Ingår i: Expert Review of Clinical Pharmacology. - : Informa UK Limited. - 1751-2433 .- 1751-2441. ; 11:10, s. 959-970
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction: For half a century, a high level of total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for cardiovascular prevention. However, there is an increasing understanding that the mechanisms are more complicated and that statin treatment, in particular when used as primary prevention, is of doubtful benefit. Areas covered: The authors of three large reviews recently published by statin advocates have attempted to validate the current dogma. This article delineates the serious errors in these three reviews as well as other obvious falsifications of the cholesterol hypothesis. Expert commentary: Our search for falsifications of the cholesterol hypothesis confirms that it is unable to satisfy any of the Bradford Hill criteria for causality and that the conclusions of the authors of the three reviews are based on misleading statistics, exclusion of unsuccessful trials and by ignoring numerous contradictory observations.
|
|
